Residual Disease Dynamics and Prognosis in Multiple Myeloma
MRD negativity, assessed via next-generation sequencing, significantly improves progression-free survival in multiple myeloma patients, according to a UCSF study. Learn more
Related Articles
Obe-cel Elicits Durable Responses in Relapsed/Refractory B-Cell ALL
In the phase 1b/2 FELIX study, obecabtagene autoleucel was associated with low incidence of grade 3 or higher immune-related toxicity.
Éliane Gluckman Receives 2024 Wallace H. Coulter Award for Lifetime Achievement in Hematology
Éliane Gluckman, MD, PhD, FRCP, of Université Paris-Cité and Saint-Louis Hospital, AP-HP, was honored with the ASH Wallace H. Coulter Award for Lifetime Achi…
Top Moffitt Research Stories of 2024
From FDA approvals to drug discovery, Moffitt led the way this past year
Allison Betof Warner, MD, PhD, on TIL Therapy for Advanced Melanoma: Innovative Clinical Advances in Treatment
Allison Betof Warner, MD, PhD, reviews important clinical research in the treatment of advanced melanoma, including tumor-infiltrating lymphocyte (TIL) therapy, the role of this innovative…
AACR-Johnson & Johnson Interventional Oncology Stimulating Therapeutic Advances through Research Training (START) Grants
Three-year grant of $225,000 to support the salary and benefits of postdoctoral or clinical research fellows conducting lung cancer research.
Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer
Introduction Non-castrating therapies are an unmet clinical need for patients with advanced prostate cancer. To maximize quality of life and prioritize cardiovascular health, we investigated…
Welcome! You are invited to join a webinar: Post-ASH 2024 MPN highlights webinar. After registering, you will receive a confirmation email about joining the webinar.
Join us to watch leading experts on MPN present summaries on the most significant abstracts from ASH 2024 followed by interactive panel discussions debating current…
An uncommon MALady: is the AnWj puzzle complete?
In this issue of Blood, Tilley and colleagues report the discovery of the gene underlying the inherited AnWj-negative phenotype.1 They identified a 6646-ba
Real-World Data Enhance Optimal Use of Cellular Therapies
The advent of cellular therapies, such as chimeric antigen receptor T-cell therapy, has revolutionized the field of hematologic malignancies.
